Immunic(IMUX.US)

Last Updated 19:00:00 ET
longbridge loading

Immunic names Michael Bonney board chair, replacing interim chair Simona Skerjanec

PUBT·
US
IMUX
+0.21%
US
MRK
+1.84%
US
BIIB
+0.40%
PUBT·
US
IMUX
+0.21%
US
MRK
+1.84%
US
BIIB
+0.40%

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors | IMUX Stock News

StockTitan·
US
IMUX
+0.21%
StockTitan·
US
IMUX
+0.21%

Immunic (IMUX) Gets a Buy from LifeSci Capital

Tip Ranks·
US
IMUX
+0.21%
US
PBE
+0.47%
US
IXJ
+1.08%
Tip Ranks·
US
IMUX
+0.21%
US
PBE
+0.47%
US
IXJ
+1.08%

IMMUNIC, INC. 1Q 2026: Revenue $0 Net loss $32.6M — 10-Q Summary

TradingView·
US
IMUX
+0.21%
US
XLV
+1.28%
US
PBE
+0.47%
TradingView·
US
IMUX
+0.21%
US
XLV
+1.28%
US
PBE
+0.47%

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | IMUX Stock News

StockTitan·
US
IMUX
+0.21%
US
IBB
+0.31%
US
ARKG
-0.85%
StockTitan·
US
IMUX
+0.21%
US
IBB
+0.31%
US
ARKG
-0.85%

06:30 ETImmunic to Participate in Investor and Medical Conferences in May

prnewswire·
US
IMUX
+0.21%
US
LABU
-2.09%
US
VHT
+1.14%
prnewswire·
US
IMUX
+0.21%
US
LABU
-2.09%
US
VHT
+1.14%
© 2026 Longbridge｜Disclaimer